Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Tipping

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Critical Care Medicine|March 21, 2002
A phase II randomized, controlled trial of continuous hemofiltration in sepsisLouise Cole, Rinaldo Bellomo, Graeme Hart, et al.
Cardiovascular Research|January 29, 2014
Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanismsAhrathy Selathurai, Virginie Deswaerte, Peter Kanellakis, et al.
Circulation Research|August 27, 2011
B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesionsTin Kyaw, Christopher Tay, Surendran Krishnamurthi, et al.
The American Journal of Pathology|December 26, 2003
Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant miceYuan H Yang, Pam Hall, Georgia Milenkovski, et al.
Plos One|January 13, 2012
Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammationTin Kyaw, Christopher Tay, Hamid Hosseini, et al.
Circulation|August 2, 2012
Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosisTam Nguyen Dinh, Tin Soe Kyaw, Peter Kanellakis, et al.
Cardiovascular Research|November 26, 2015
A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammationYi Li, Peter Kanellakis, Hamid Hosseini, et al.
Cardiovascular Research|February 15, 2015
Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytesHamid Hosseini, Yi Li, Peter Kanellakis, et al.
Circulation|February 12, 2013
Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient miceTin Kyaw, Amy Winship, Christopher Tay, et al.
Cardiovascular Research|August 6, 2016
B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammationChristopher Tay, Yu-Han Liu, Hamid Hosseini, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Critical Care Medicine|March 21, 2002
A phase II randomized, controlled trial of continuous hemofiltration in sepsisLouise Cole, Rinaldo Bellomo, Graeme Hart, et al.
Cardiovascular Research|January 29, 2014
Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanismsAhrathy Selathurai, Virginie Deswaerte, Peter Kanellakis, et al.
Circulation Research|August 27, 2011
B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesionsTin Kyaw, Christopher Tay, Surendran Krishnamurthi, et al.
The American Journal of Pathology|December 26, 2003
Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant miceYuan H Yang, Pam Hall, Georgia Milenkovski, et al.
Plos One|January 13, 2012
Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammationTin Kyaw, Christopher Tay, Hamid Hosseini, et al.
Circulation|August 2, 2012
Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosisTam Nguyen Dinh, Tin Soe Kyaw, Peter Kanellakis, et al.
Cardiovascular Research|November 26, 2015
A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE-/- mice by reducing lesion necrosis and inflammationYi Li, Peter Kanellakis, Hamid Hosseini, et al.
Cardiovascular Research|February 15, 2015
Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytesHamid Hosseini, Yi Li, Peter Kanellakis, et al.
Circulation|February 12, 2013
Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient miceTin Kyaw, Amy Winship, Christopher Tay, et al.
Cardiovascular Research|August 6, 2016
B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammationChristopher Tay, Yu-Han Liu, Hamid Hosseini, et al.
Pageof 3